A detailed history of Vr Adviser, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 9,825,000 shares of APLT stock, worth $87.5 Million. This represents 8.65% of its overall portfolio holdings.

Number of Shares
9,825,000
Previous 9,542,871 2.96%
Holding current value
$87.5 Million
Previous $44.6 Million 87.39%
% of portfolio
8.65%
Previous 4.89%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.35 - $8.5 $1.23 Million - $2.4 Million
282,129 Added 2.96%
9,825,000 $83.5 Million
Q2 2024

Aug 14, 2024

BUY
$4.04 - $6.37 $1.89 Million - $2.98 Million
467,871 Added 5.16%
9,542,871 $44.6 Million
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $6.36 Million - $20.9 Million
2,825,000 Added 45.2%
9,075,000 $61.7 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $1.09 Million - $1.98 Million
591,966 Added 10.46%
6,250,000 $20.9 Million
Q2 2023

Aug 11, 2023

BUY
$0.77 - $1.8 $4.36 Million - $10.2 Million
5,658,034 New
5,658,034 $7.24 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $428M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.